Overview

• The $5,999 Nucleus Embryo service lets parents upload up to 20 embryo genomes for analysis across nearly 900 health and trait markers.
• Using whole-genome data from partner Genomic Prediction, the platform generates polygenic risk scores to estimate projected IQ, height, eye color and risk for cancers, Alzheimer’s and other diseases.
• CEO Kian Sadeghi frames the tool as part of the longevity movement, arguing that early genetic insights can reduce chronic disease and extend healthy lifespan.
• Company materials acknowledge that trait forecasts are probabilistic and “limited in accuracy,” with IQ predictions attracting particular scrutiny.
• Bioethicists warn that the unregulated ranking system could encourage societal preferences for certain children and revive modern eugenics concerns.